These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12151853)

  • 1. Inflammatory markers and coronary heart disease.
    Rifai N; Ridker PM
    Curr Opin Lipidol; 2002 Aug; 13(4):383-9. PubMed ID: 12151853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease.
    Rifai N; Ridker PM
    Clin Chem; 2001 Mar; 47(3):403-11. PubMed ID: 11238289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment.
    Benzaquen LR; Yu H; Rifai N
    Crit Rev Clin Lab Sci; 2002 Sep; 39(4-5):459-97. PubMed ID: 12385503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease.
    Rosenson RS; Koenig W
    Curr Opin Cardiol; 2002 Jul; 17(4):325-31. PubMed ID: 12151864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation markers and coronary heart disease.
    Tracy RP
    Curr Opin Lipidol; 1999 Oct; 10(5):435-41. PubMed ID: 10554706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of outcome from cardiovascular disease.
    Khuseyinova N; Koenig W
    Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy.
    Yu H; Rifai N
    Clin Biochem; 2000 Nov; 33(8):601-10. PubMed ID: 11166006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper.
    Biasucci LM; ;
    Circulation; 2004 Dec; 110(25):e560-7. PubMed ID: 15611382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
    Ridker PM; Rifai N; Clearfield M; Downs JR; Weis SE; Miles JS; Gotto AM;
    N Engl J Med; 2001 Jun; 344(26):1959-65. PubMed ID: 11430324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
    Danesh J; Wheeler JG; Hirschfield GM; Eda S; Eiriksdottir G; Rumley A; Lowe GD; Pepys MB; Gudnason V
    N Engl J Med; 2004 Apr; 350(14):1387-97. PubMed ID: 15070788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease.
    Schumacher A; Peersen K; Sommervoll L; Seljeflot I; Arnesen H; Otterstad JE
    Eur J Cardiovasc Prev Rehabil; 2006 Jun; 13(3):356-62. PubMed ID: 16926664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammation in acute coronary syndromes: mechanisms and clinical implications].
    Angiolillo DJ; Biasucci LM; Liuzzo G; Crea F
    Rev Esp Cardiol; 2004 May; 57(5):433-46. PubMed ID: 15151777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of inflammation and their clinical significance.
    Ballantyne CM; Nambi V
    Atheroscler Suppl; 2005 May; 6(2):21-9. PubMed ID: 15823493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.
    Packard CJ; O'Reilly DS; Caslake MJ; McMahon AD; Ford I; Cooney J; Macphee CH; Suckling KE; Krishna M; Wilkinson FE; Rumley A; Lowe GD
    N Engl J Med; 2000 Oct; 343(16):1148-55. PubMed ID: 11036120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and other inflammatory risk markers in acute coronary syndromes.
    Blake GJ; Ridker PM
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):37S-42S. PubMed ID: 12644339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indicators of inflammation in patients with coronary atherosclerosis - role of usCRP in diagnosis and disease progression prediction].
    Samoš M; Pullmann R; Funiak S; Stančík M; Mokáň M
    Vnitr Lek; 2013 Dec; 59(12):1057-64. PubMed ID: 24350937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.